1. Home
  2. SGHT vs MCN Comparison

SGHT vs MCN Comparison

Compare SGHT & MCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGHT
  • MCN
  • Stock Information
  • Founded
  • SGHT 2011
  • MCN 2004
  • Country
  • SGHT United States
  • MCN Canada
  • Employees
  • SGHT N/A
  • MCN N/A
  • Industry
  • SGHT Medical Specialities
  • MCN
  • Sector
  • SGHT Health Care
  • MCN
  • Exchange
  • SGHT Nasdaq
  • MCN Nasdaq
  • Market Cap
  • SGHT 140.1M
  • MCN 115.9M
  • IPO Year
  • SGHT 2021
  • MCN N/A
  • Fundamental
  • Price
  • SGHT $3.22
  • MCN $5.54
  • Analyst Decision
  • SGHT Buy
  • MCN
  • Analyst Count
  • SGHT 7
  • MCN 0
  • Target Price
  • SGHT $3.83
  • MCN N/A
  • AVG Volume (30 Days)
  • SGHT 189.8K
  • MCN 52.9K
  • Earning Date
  • SGHT 05-08-2025
  • MCN 01-01-0001
  • Dividend Yield
  • SGHT N/A
  • MCN 9.96%
  • EPS Growth
  • SGHT N/A
  • MCN N/A
  • EPS
  • SGHT N/A
  • MCN N/A
  • Revenue
  • SGHT $79,866,000.00
  • MCN N/A
  • Revenue This Year
  • SGHT N/A
  • MCN N/A
  • Revenue Next Year
  • SGHT $11.17
  • MCN N/A
  • P/E Ratio
  • SGHT N/A
  • MCN N/A
  • Revenue Growth
  • SGHT N/A
  • MCN N/A
  • 52 Week Low
  • SGHT $2.03
  • MCN $6.69
  • 52 Week High
  • SGHT $8.45
  • MCN $8.60
  • Technical
  • Relative Strength Index (RSI)
  • SGHT 67.25
  • MCN 41.97
  • Support Level
  • SGHT $2.40
  • MCN $5.16
  • Resistance Level
  • SGHT $3.44
  • MCN $5.62
  • Average True Range (ATR)
  • SGHT 0.28
  • MCN 0.19
  • MACD
  • SGHT 0.11
  • MCN 0.02
  • Stochastic Oscillator
  • SGHT 84.40
  • MCN 82.61

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

About MCN Madison Covered Call & Equity Strategy Fund

XAI Madison Equity Premium Income Fund is an investment management company. The Fund invests in an actively managed equity portfolio comprised of individual stocks and covered call options. The Fund's primary investment objective is to provide high level of current income and gains, with a secondary objective of capital appreciation.

Share on Social Networks: